Pozvánka: konference "5th Annual Protein Kinases in Drug Discovery", 27. - 28. 5. 2010

5th Annual Protein Kinases in Drug Discovery Conference
May 27-28, 2010 in Boston, MA
Register now to save up to $300

Dear Colleague,

Protein kinases play major roles in many cellular processes. Altered expression or function often results in various abnormal cellular phenotypes. In the last 10 years, there was a tremendous success at developing kinase inhibitors to treat cancer, metabolic diseases, autoimune diseases and other medical conditions. The success of early kinase drug development depend on the understanding of their cellular mechanisms and viable strategies of drug development, a combination that can be found from GTCbio's 5th Annual Protein Kinases in Drug Discovery conference on May 27-28, 2010 in Boston, MA. Leading experts from organizations such as Harvard Univ., Tufts Univ., UCSD, Dartmouth, Johns Hopkins,  Hoffmann-La Roche, Abbott, AstraZeneca, GlaxoSmithKline, Genentech, Merck, Pfizer, Sanofi-Aventis and Wyeth will be presenting at this exciting event.

>> Click here to submit an abstract. Deadline: April 27, 2010.
>> Register by March 27 to save up to $300. *Refer a friend and win!

Conference Sessions:

Session I: Drug Design Trends - Structure / Selectivity / Pathway
Session II: Overcoming Challenges of Kinase Drug Development
Session III: Pre-Clinical Kinase Targets to Clinical Trials
Session IV: Novel Kinases and Inhibitor Candidates
- Serine / Threonine Kinases
- Tyrosine Kinases
- Pyruvate Kinases
- Lipid Kinases
- Sugar Kinases

>> Click here to see the detailed agenda.
>> Register 2, the 3rd person goes free!

Distinguished Speakers:

+ David Goldstein, Ph.D., Senior Director, Discovery Chemistry, Hoffmann-La Roche
+ David Calderwood, Ph.D., Associate Director, Chemistry, Abbott
+ Andrew Crew, Ph.D., Director, Cancer Chemistry, OSI Pharmaceuticals
+ Michael Crouch, Ph.D., Chief Scientific Officer, TGR-Biosciences
+ Alexei Degterev, Ph.D., Assistant Professor, Tufts University
+ Keith T. Flaherty, M.D., Director of Devel. Therapeutics, Massachusetts General Hospital
+ Marcie Glicksman, Ph.D., Co-Director, Laboratory for Drug Discovery, Harvard NeuroDiscovery Center
+ Frederick Golberg, Ph.D., Medicinal Chemist Team Leader, AstraZeneca
+ Said Goueli, Ph.D., Tech Dev Team Leader, Promega
+ Jonathan M.G. Higgins, B.A. D.Phil., Assistant Professor, BW Hospital, Harvard Medical School
+ Anthony E. Klon, Ph.D., Senior Scientist, Computational Chemistry, Ansaris
+ Alexandr Kornev, Ph.D., Howard Hughes Medical Institute, UCSD
+ Michael Kubbutat, Ph.D., Head Research & Development, ProQinase GmbH
+ Karen Leach, Ph.D., Compound Safety Prediction, Pfizer
+ Hong Lin, Ph.D., Investigator, Oncology Research and Development, GlaxoSmithKline
+ Yi Liu, Ph.D., Vice President, Drug Discovery, Biology, Intellikine
+ Karen Maegley, Ph.D., Associate Research Fellow, Pfizer Global Research
+ Shiva Malek, Ph.D., Scientist, Small Molecule Drug Discovery, Genentech
+ Neil D. Moorcroft, Research Scientist, Sanofi-Aventis
+ Mark J. Mulvihill, Ph.D., Director of Chemistry, Oncology, OSI Pharmaceuticals
+ Jeffrey R. Peterson, Ph.D., Assistant Professor, Fox Chase Cancer Center
+ William J. Pitts, Ph.D., Senior Principal Scientist, Discovery Chemistry, Bristol-Myers Squibb
+ Zhao Ren, Ph.D., Elan Pharmaceuticals
+ R. Brooks Robey, M.D., F.A.S.N., F.A.H.A., Associate Professor, Dartmouth Medical School
+ Jeffrey Simard, Ph.D., Project Leader, Chemical Genomics Centre, Max-Planck-Society
+ Sucha Sudarsanam, M.S., Chief Scientific Officer, Emiliem
+ Jim Tomlinson, Ph.D., Scientific Director, KAI Pharmaceuticals
+ Matthew L. Tripp, Ph.D., Senior VP, R&D, KinDex Therapeutics
+ Arkadii Vaisburg, Ph.D., Executive Director, Medicinal Chemistry, MethylGene
+ Andrew West, Ph.D., Assistant Professor of Neurology, Johns Hopkins
+ Guido J.R. Zaman, Ph.D., GPCR & Kinases, Merck Research Laboratories
+ Arie Zask, Wyeth

>> Click here for a Full Speaker List

*Refer a friend and win! If you refer this conference to any of your colleagues and they register to attend, you will receive $50 for every person that signs up. Once you forward the conference information to your colleagues, simply send a list of their names and contact information and the conference you are referring to infogtcbio@gtcbio.com and we will keep record until your colleague signs up!

Business Development & Exhibiting Opportunities contact Nina at 626-256-6405 x105 or gtcsales@gtcbio.com